Assessment of ATRX Expression in Patients With Myelodysplastic Syndromes Treated With Decitabine

Leukemia Research - United Kingdom
doi 10.1016/j.leukres.2008.11.030
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Fas/Apo-1(cd95) Expression and Apoptosis in Patients With Myelodysplastic Syndromes

Leukemia
Cancer ResearchOncologyAnesthesiologyPain MedicineHematology
1997English

Survival Advantage With Decitabine Versus Intensive Chemotherapy in Patients With Higher Risk Myelodysplastic Syndrome

Cancer
Cancer ResearchOncology
2007English

Comparison of Risk Stratification Tools in Predicting Outcomes of Patients With Higher-Risk Myelodysplastic Syndromes Treated With Azanucleosides

Leukemia
Cancer ResearchOncologyAnesthesiologyPain MedicineHematology
2015English

Improving Prognostic Tools for Patients With Myelodysplastic Syndromes

Mayo Clinic Proceedings
Medicine
2018English

Landscape of Genetic Lesions in 944 Patients With Myelodysplastic Syndromes

Leukemia
Cancer ResearchOncologyAnesthesiologyPain MedicineHematology
2013English

Assessment of Treatment-Related Myelodysplastic Syndromes and Acute Myeloid Leukemia in Patients With Non-Hodgkin Lymphoma Treated With Tositumomab and Iodine I131 Tositumomab

Blood
BiochemistryImmunologyCell BiologyHematology
2005English

Management of Cytopenias During Treatment With Lenalidomide in Patients With Myelodysplastic Syndromes

The Open Leukemia Journal
2010English

Expression Significance and Potential Mechanism of Hypoxia‐inducible Factor 1 Alpha in Patients With Myelodysplastic Syndromes

Cancer Medicine
Cancer ResearchNuclear MedicineRadiologyImagingOncology
2019English

Hematopoietic Stem Cell Transplantation for Older Patients With Myelodysplastic Syndromes

Journal of the National Comprehensive Cancer Network : JNCCN
MedicineOncology
2013English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy